SEC Form 4 · accession 0001193125-26-361391
MYOMO, INC. · MYO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Harry Kovelman
Officer — Chief Medical Officer
Period of report
Aug 20, 2026
Accepted (ET)
Aug 21, 2026 · 6:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001369290
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2026 | S | 17,250 | $1.7331 | D | 105,983 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents weighted average sales price. Shares sold in open market transactions in multiple lots at prices ranging from $1.72 to $1.75 per share. Reporting party agrees to provide details of the transactions to the SEC upon request.